Cargando…
Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma
Adult and pediatric high-grade gliomas (HGGs) are aggressive cancers of the central nervous system that confer dismal clinical prognoses. Standard radiation and chemotherapy have demonstrated only limited efficacy in HGGs, motivating the accelerated investigation of novel modalities such as oncolyti...
Autores principales: | Bernstock, Joshua D, Blitz, Sarah E, Hoffman, Samantha E, Gerstl, Jakob V E, Chiocca, E Antonio, Friedman, Gregory K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368374/ https://www.ncbi.nlm.nih.gov/pubmed/37497017 http://dx.doi.org/10.1093/noajnl/vdad081 |
Ejemplares similares
-
Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade glioma
por: Karandikar, Paramesh V., et al.
Publicado: (2023) -
Tumor-Associated Macrophages/Microglia in Glioblastoma Oncolytic Virotherapy: A Double-Edged Sword
por: Blitz, Sarah E., et al.
Publicado: (2022) -
Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?
por: Koks, Carolien A.E., et al.
Publicado: (2015) -
Oncolytic Virotherapy in Glioma Tumors
por: Rius-Rocabert, Sergio, et al.
Publicado: (2020) -
Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2013)